• Global production capacity: Across its India and Egypt operations, Asepto has a combined capacity of 24 billion packs targeting a 300 billion pack global market, ranking among the top five players worldwide.
• Egypt strategic logistics: Manufacturing in Egypt grants duty-free market access to Europe and the Arab League while enabling overland truck deliveries to the GCC, insulating supply chains from maritime shipping disruptions in the Red Sea and Strait of Hormuz.
• Pharma segment outlook: Liquid pharmaceuticals and hospital oral feeds represent the next major growth frontier, with initial demand anticipated from Asia and India due to ambient shelf-life requirements and cold-chain constraints.
• Utilization and IPO: Following a consistent 35% CAGR, management is focusing on Egypt capacity utilization targets of 30% in year one, 70% in year two, and 100% in year three, ruling out any IPO plans for at least three years.
• Sustainability and innovation: The company addresses industry sustainability challenges through a chemical-free enzymatic delamination process that separates packaging layers for circular recycling.